Pregabalin Capsule
Product Images NDC 60219-1313

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 60219-1313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 (Pregabalin Capsules Us 1)

This is a formula for calculating creatinine clearance (CLCr) in adults based on age, weight, and serum creatinine levels. It is important to note that the formula differs slightly for female patients as it involves multiplying the result by 0.85.*

FDA Label Image

F-8 (Pregabalin Capsules Us 10)

This document appears to be a chart or table showing different doses of Pregabalin and a placebo, and the percent improvement in pain from the baseline for patients taking these different doses. The doses listed are 450mg/day, 100mg/day, and a placebo. The text is not fully readable and there may be additional information that is not available.*

FDA Label Image

Fig-9 (Pregabalin Capsules Us 11)

The given text is a table presenting data on the estimated percentage of subjects without LTR (Likely Therapeutic Response) for Pregabalin and Placebo over a period of 180 days. The percentage ranges from 100% to 10% with a 10% increment. The data is plotted against the number of days on the x-axis.*

FDA Label Image

F-10 (Pregabalin Capsules Us 12)

The data shows the percentage of subjects who improved from the baseline to week 12 using pregabalin compared to a placebo. The percentages range from 90% to 100%. There are also some numbers listed under "T" and "BOCF," but without additional context, it is unclear what they mean.*

FDA Label Image

F-11 (Pregabalin Capsules Us 13)

FDA Label Image

25 mg Label (Pregabalin Capsules Us 14)

This text describes a medication called Pregabalin Capsules. The medication guide is provided separately and it should only be dispensed with a prescription. The capsule contains 25 mg pregabalin and usual dosage should be followed as per the prescribing information. It can be stored between 20° to 25°C with certain excursions permitted. Dispensing should be done in a tight container with child-resistant closure as per the USP. It is distributed by Amneal Pharmaceuticals LLC in New Jersey. The text also includes information about the lot and expiration dates.*

FDA Label Image

50 mg Label (Pregabalin Capsules Us 15)

This is a description of Pregabalin Capsules, each containing 50 mg of Pregabalin. The usual dosage instructions can be found in the prescribing information. The medication guide should be dispensed separately, and it should be stored in a tight container with a child-resistant closure at controlled room temperature. The drug is manufactured by the Bridgewater company, and the package was revised in October 2019.*

FDA Label Image

75 mg Label (Pregabalin Capsules Us 16)

This is a description for a medication named Pregabalin Capsules. The pharmacist is instructed to dispense 90 capsules to the patient along with the medication guide. Each capsule consists of 75 mg pregabalin. The usual dosage can be found in the accompanying prescribing information. It should be stored at 20" to 25°C, with excursions permitted between 15° to 30°C. This medication should be dispensed in a tight container with a child-resistant closure. It is distributed by Amneal Pharmaceuticals LLC based in Bridgewater, NJ. The text also includes details about lot and expiry date.*

FDA Label Image

100 mg Label (Pregabalin Capsules Us 17)

This text provides information about Pregabalin Capsules, which contain 100mg of pregabalin per capsule. The recommended dosage is not stated here and should be found in the accompanying prescribing information. The capsules should be stored at 20-25°C with excursions permitted between 15-30°C. Dispensing should be done with a tight container with a child-resistant closure. The manufacturer is Amneal Pharmaceuticals LLC based in Bridgewater, NJ.*

FDA Label Image

200 mg Label (Pregabalin Capsules Us 18)

This is a description of a medication called Pregabalin contained in capsules with dosage information and storage instructions. The medication should be dispensed with a medication guide and should be stored between 20°C to 25°C. The medication is distributed by Amneal Pharmaceuticals LLC and the packaging contains the company's address.*

FDA Label Image

225 mg Label (Pregabalin Capsules Us 19)

This is a medication description for NDC 60219-1316-9 capsules containing 225mg pregabalin. The usual dosage information is provided in the accompanying prescribing information. The capsules should be stored between 20-25°C (68-77°F) and excursions between 15-30°C (59-86°F) are permitted according to USP Controlled Room Temperature guidelines. The pharmacist should dispense the capsules in a tightly closed container with a child-resistant closure and provide a medication guide separately. These capsules are distributed by Amneal Pharmaceuticals LLC.*

FDA Label Image

Structure (Pregabalin Capsules Us 2)

FDA Label Image

300 mg Label (Pregabalin Capsules Us 20)

This is a description of Pregabalin Capsules, a medication that contains 300mg of pregabalin per capsule. The accompanying prescribing information should be consulted for the usual dosage. The medication should be stored between 20-25°C, and dispensed in a tight container with a child-resistant closure, as defined in the USP. Amneal Pharmaceuticals LLC, based in Brdigewater, NJ, distributes the medication. There is also information on the non-varnish area for the lot and expiration date.*

FDA Label Image

150 mg Label (Pregabalin Capsules Us 21)

This is a medication label for capsules containing 150mg of pregabalin, with dosage information available in the accompanying prescribing information. The capsules should be stored at a temperature range of 20°C to 25°C and dispensed in a tight container with a child-resistant closure. A medication guide is provided separately. This medication was distributed by Amneal Pharmaceuticals LLC and the label was revised in October 2019.*

FDA Label Image

F1 (Pregabalin Capsules Us 3)

The text is describing a chart that displays the percent of patients that have experienced improvement, and the percent of improvement in pain from the baseline. It is not possible to provide more details as some text is missing and the context is unclear.*

FDA Label Image

F-2 (Pregabalin Capsules Us 4)

The text is not clear and coherent. The output seems to be distorted and incomplete. It is not possible to generate a useful description from this text.*

FDA Label Image

F-3 (Pregabalin Capsules Us 5)

FDA Label Image

F-4 (Pregabalin Capsules Us 6)

FDA Label Image

F-5 (Pregabalin Capsules Us 7)

This appears to be a data table showing different treatments for pain and their corresponding percentage of improvement from baseline. Three treatments are listed: Pregatalin 100mg taken three times a day, Pregabalin 0mg taken three times a day, and Placeta (presumably a placebo). The table also includes a chart indicating percentage improvement in pain from baseline. However, the output contains a lot of errors and is not very clear, making it difficult to provide more details.*

FDA Label Image

F-6 (Pregabalin Capsules Us 8)

FDA Label Image

F-7 (Pregabalin Capsules Us 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.